Philip Morris International reported total net revenues of $10.15 billion for the first quarter of fiscal 2026, representing a 9.1% increase year-over-year. Adjusted diluted EPS rose 16.0% to $1.96 from $1.69 in the prior-year period, beating consensus expectations. Performance was primarily driven by exceptional momentum across the international smoke-free portfolio, led by robust IQOS volume expansion and strong pricing execution within international combustible lines that fully offset a 5.1% drop in traditional cigarette shipments.
Note: Philip Morris International's FY'25 ended on December 31, 2025. Q1 FY'26 ended on March 31, 2026.
The company implemented an evolved global organizational structure effective January 1, 2026, officially realigning its financial reporting into three distinct business units: International Smoke-Free, International Combustibles, and U.S. This structural transition reflects the company's massive multi-year pivot away from combustible products, optimizing resource allocation and offering clearer strategic tracking into its scaling alternative nicotine business lines.
Below are key drivers of Philip Morris International's value that present opportunities for upside or downside to the current Trefis price estimate:
For additional details, select a division from the interactive Trefis split for Philip Morris International at the top of the page.
Philip Morris International operates as a premier global consumer goods company focused on the manufacturing and sale of traditional combustible tobacco products alongside the rapid commercialization of next-generation, non-combustible smoke-free alternatives.
The International Smoke-Free segment has emerged as the most critical pillar of the company's valuation due to its premium unit economics and secular growth potential.
IQOS holds approximately 77% volume share in the global heat-not-burn category and has surpassed Marlboro as the number one nicotine brand in markets where it operates at scale, creating excellent consumer retention.
Next-generation smoke-free alternatives generate 2.5 times higher revenue and 2.6 times more gross profit per unit than traditional cigarettes, giving the company structural gross margin expansion potential as the product mix transforms.
Adult consumer preferences and public health frameworks are structurally migrating toward non-combustible alternatives, driving massive international growth in oral nicotine pouches, heated tobacco units, and closed-pod e-vapor devices.
Management is focusing its core operational strategy on expanding smoke-free manufacturing facilities worldwide while maintaining disciplined capital allocation to bring its net debt to adjusted EBITDA ratio close to 2.0x by the end of 2026.
